Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Kerr

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
New secondary metabolites of phenylbutyrate in humans and ratsTakhar Kasumov, Laura L Brunengraber, Blandine Comte, et al.
Journal of Neuroimmunology|December 8, 2007
Cleavage of myelin associated glycoprotein by matrix metalloproteinasesElizabeth Milward, Kee Jun Kim, Arek Szklarczyk, et al.
Journal of Neuromuscular Diseases|April 5, 2018
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn ScreeningJacqueline Glascock, Jacinda Sampson, Amanda Haidet-Phillips, et al.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
JIMD Reports|November 18, 2020
Utility of specific amino acid ratios in screening for pyruvate dehydrogenase complex deficiencies and other mitochondrial disorders associated with congenital lactic acidosis and newborn screening prospectsJirair K Bedoyan, Rosemary Hage, Ha Kyung Shin, et al.
Molecular Genetics and Metabolism|May 23, 2022
Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC)Valentina Emmanuele, Jaya Ganesh, Georgirene Vladutiu, et al.
Neuromuscular Disorders : NMD|November 10, 2019
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyDarryl C De Vivo, Enrico Bertini, Kathryn J Swoboda, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 30, 2008
The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditionsAlan Regenberg, Debra J H Mathews, David M Blass, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2015
Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in NeurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
New secondary metabolites of phenylbutyrate in humans and ratsTakhar Kasumov, Laura L Brunengraber, Blandine Comte, et al.
Journal of Neuroimmunology|December 8, 2007
Cleavage of myelin associated glycoprotein by matrix metalloproteinasesElizabeth Milward, Kee Jun Kim, Arek Szklarczyk, et al.
Journal of Neuromuscular Diseases|April 5, 2018
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn ScreeningJacqueline Glascock, Jacinda Sampson, Amanda Haidet-Phillips, et al.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
JIMD Reports|November 18, 2020
Utility of specific amino acid ratios in screening for pyruvate dehydrogenase complex deficiencies and other mitochondrial disorders associated with congenital lactic acidosis and newborn screening prospectsJirair K Bedoyan, Rosemary Hage, Ha Kyung Shin, et al.
Molecular Genetics and Metabolism|May 23, 2022
Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC)Valentina Emmanuele, Jaya Ganesh, Georgirene Vladutiu, et al.
Neuromuscular Disorders : NMD|November 10, 2019
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyDarryl C De Vivo, Enrico Bertini, Kathryn J Swoboda, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 30, 2008
The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditionsAlan Regenberg, Debra J H Mathews, David M Blass, et al.
Pageof 3